UM
(Note: the search results are based on claimed items)

Browse/Search Results:  1-2 of 2 Help

Filters        
Selected(0)Clear Items/Page:    Sort:
Osimertinib (AZD9291) decreases programmed death ligand-1 in EGFR-mutated non-small cell lung cancer cells Journal article
ACTA PHARMACOLOGICA SINICA, 2017,Volume: 38,Issue: 11,Page: 1512-1520
Authors:  Jiang, Xiao-Ming;  Xu, Yu-Lian;  Huang, Mu-Yang;  Zhang, Le-Le;  Su, Min-Xia;  Chen, Xiuping;  Lu, Jin-Jian
Favorite  |  View/Download:25/0  |  Submit date:2018/10/30
Non-small Cell Lung Cancer  Egfr  Osimertinib  Pd-l1  Ubiquitin-proteasome System  Mg-132  Bortezomib  Gsk3 Beta  Licl  
Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells Journal article
Biochemical Pharmacology, 2010,Volume: 80,Issue: 1,Page: 22-30
Authors:  Lu J.-J.;  Meng L.-H.;  Shankavaram U.T.;  Zhu C.-H.;  Tong L.-J.;  Chen G.;  Lin L.-P.;  Weinstein J.N.;  Ding J.
Favorite  |  View/Download:5/0  |  Submit date:2018/12/28
Apoptosis  C-myc  Dihydroartemisinin  Gsk 3β  Nci-60